Advertisement

Epidemiology of Group B Coxsackieviruses

  • Mark A. Pallansch
Part of the Infectious Agents and Pathogenesis book series (IAPA)

Abstract

The Coxsackie B viruses (CVB) are members of the genus Enterovirus and share many properties with other members of this group. There are several excellent reviews covering the basic epidemiology and clinical characteristics of enteroviruses and their infections1–4; this material is not repeated in detail, except as it relates to recent studies. Most of the conclusions concerning enteroviruses in general are directly applicable to CVB, including seasonality; geographic, age, and sex distribution; incidence and prevalence; transmission; and most clinical syndromes.

Keywords

Human Leukocyte Antigen Acute Flaccid Paralysis Acute Myocarditis Coxsackie Virus Human Leukocyte Antigen Type 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Melnick, J. L., 1982, Enteroviruses, in: Viral Infections of Humans, Epidemiology and Control (A. S. Evans, ed.), pp. 187–251, Plenum, New York.Google Scholar
  2. 2.
    Moore, M., and Morens, D. M., 1984, Enteroviruses, including polioviruses, in: Textbook of Human Virology (R. B. Belshe, ed.), pp. 407–483, PSG, Littleton, Massachusetts.Google Scholar
  3. 3.
    Melnick, J. L., 1985, Enteroviruses: Polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses, in: Virology (B. N. Fields, D. M. Knipe, R. M. Chanock, J. L. Melnick, B. Roizman, and R. E. Shope, eds.), pp. 739–794, Raven, New York.Google Scholar
  4. 4.
    Modlin, J. F., 1985, Coxsackievirus and echovirus, in: Pńnciples and Practices of Infectious Diseases (G. L. Mandell, R. G. Douglas, Jr., and J. E. Bennett, eds.), pp. 814–825, Wiley, New York.Google Scholar
  5. 5.
    Strikas, R. A., Anderson, L. J., and Parker, R. A., 1986, Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970–1983,J. Infect. Dis. 153:346–351.Google Scholar
  6. 6.
    Bell, E. J., and McCartney, R. A., 1984, A study of Coxsackie B virus infections, 1972–1983, J. Hyg. (Lond.) 93:197–204.Google Scholar
  7. 7.
    Schoub, B. D., Johnson, S., McAnerney, J. M., Dos Santos, I. L., and Klaassen, K. I., 1985, Epidemic Coxsackie B virus infection in Johannesburg, South Africa, J. Hyg. (Lond.) 95:447–455.Google Scholar
  8. 8.
    Centers for Disease Control, 1970, Neurotropic Viral Diseases Surveillance, Enterovirus Infections, Annual Summary, 1969, Centers for Disease Control, Atlanta, Georgia.Google Scholar
  9. 9.
    Centers for Disease Control, 1970, Neurotropic Viral Diseases Surveillance, Enterovirus Infections, January—September, 1970, Centers for Disease Control, Atlanta, Georgia.Google Scholar
  10. 10.
    Centers for Disease Control, 1971, Neurotropic Diseases Surveillance, Enterovirus Infections, Annual Summary, 1970, Centers for Disease Control, Atlanta, Georgia.Google Scholar
  11. 11.
    Centers for Disease Control, 1977, Enteńc and Neurotropic Diseases Surveillance, Enterovirus Surveillance, 1971–1975, Centers for Disease Control, Atlanta, Georgia.Google Scholar
  12. 12.
    Centers for Disease Control, 1981, Enterovirus Surveillance, Summary 1970–1979, Centers for Disease Control, Atlanta, Georgia.Google Scholar
  13. 13.
    Morens, D. M., Zweighaft, R. M., and Bryan, J. M., 1979, Non-polio enterovirus disease in the United States, 1971–1975, Int. J. Epidemiol. 8:49–54.PubMedGoogle Scholar
  14. 14.
    Moore, M., 1982, Enteroviral disease in the United States, 1970–1979,J. Infect. Dis. 146:103–108.PubMedGoogle Scholar
  15. 15.
    Prabhakar, B. S., Haspel, M. V., McClintock, P. R., and Notkins, A. L., 1982, High frequency of antigenic variants among naturally occurring human Coxsackie B4 virus isolates identified by monoclonal antibodies, Nature (Lond.) 300:374–376.Google Scholar
  16. 16.
    Prabhakar, B. S., Menegus, M. A., and Notkins, A. L., 1985. Detection of conserved and nonconserved epitopes on coxsackievirus B4: Frequency of antigenic change, Virology 146:302–306.PubMedGoogle Scholar
  17. 17.
    Webb, S. R., Kearse, K. P., Foulke, C. L., Hartig, P. C., and Prabhakar, B. S., 1986, Neutralization epitope diversity of coxsackievirus B4 isolates detected by monoclonal antibodies,J. Med. Virol. 20:9–15.PubMedGoogle Scholar
  18. 18.
    Ash, P., Leong, W. A., Kennett, M. L., and Schnagl, R. D., 1985, Neutralization kinetic analysis of echovirus-30 and coxsackievirus-B4 strains revealed little antigenic variation amongst the echovirus strains, Aust. J. Exp. Biol. Med. Sci. 63:219–222.PubMedGoogle Scholar
  19. 19.
    Nottay, B. K., Kew, O. M., Hatch, M. H., Heyward, J. T., and Obijeski, J. F., 1981, Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans, Virology 108:405–423.PubMedGoogle Scholar
  20. 20.
    Minor, P. D., 1982, Characterization of strains of type 3 poliovirus by oligonucleotide mapping,J. Gen. Virol. 59:307–317.PubMedGoogle Scholar
  21. 21.
    Kew, O. M., and Nottay, B. K., 1984, Molecular epidemiology of polioviruses, Rev. Infect. Dis. 6:S499–S504.PubMedGoogle Scholar
  22. 22.
    Harris, T. J. R., Doel, T. R., and Brown, F., 1977, Molecular aspects of the antigenic variation of swine vesicular disease and Coxsackie B5 viruses, J. Gen. Virol. 35:299–315.PubMedGoogle Scholar
  23. 23.
    Cao, Y., Schnurr, D. P., and Schmidt, N.J., 1984, Monoclonal antibodies for study of antigenic variation in coxsackievirus type B4—Association of antigenic determinants with myocarditic properties of the virus,J. Gen. Virol. 65:925–932.PubMedGoogle Scholar
  24. 24.
    Cao, Y., Schnurr, D. P., and Schmidt, N.J., 1984, Differing cardiotropic and myocarditic properties of group B type 4 coxsackievirus strains, Arch. Virol. 80:119–130.PubMedGoogle Scholar
  25. 25.
    Jordan, G. W., Bolton, V., and Schmidt, N.J., 1985, Diabetogenic potential of Coxsackie B viruses in nature, Arch. Virol. 86:213–221.PubMedGoogle Scholar
  26. 26.
    Jimes, S., and Jamison, R. M., 1983, Coxsackievirus B4: In vitro genetic markers and virulence, Arch. Virol. 77:1–11.PubMedGoogle Scholar
  27. 27.
    Jimes, S., Jamison, R. M., and Grafton, W. D., 1984, Coxsackievirus B4: In vitro genetic markers and cardiovirulence, Arch. Virol. 81:345–352.PubMedGoogle Scholar
  28. 28.
    Jordan, G. W., and Bolton, V., 1985, Interferon-sensitive coxsackievirus variants in nature,J. Interferon Res. 5:289–296.PubMedGoogle Scholar
  29. 29.
    Hartig, P. C., and Webb, S. R., 1983, Heterogeneity of a human isolate of Coxsackie B4: Biological differences,J. Infection. 6:43–48.Google Scholar
  30. 30.
    Hartig, P. C., Madge, G. E., and Webb, S. R., 1983, Diversity within a human isolate of Coxsackie B4: Relationship to viral-induced diabetes,J. Med. Virol. 11:23–30.PubMedGoogle Scholar
  31. 31.
    Danes, L., and Jaresova, I., 1985, Neutralization microtest with human coxsackievirus and echovirus serotypes, J. Hyg. Epidemiol. Microbiol. Immunol. 29:399–408.Google Scholar
  32. 32.
    Manjunath, N., Balaya, S., and Seth, P., 1982, Serologic survey for neutralizing antibodies against group B coxsackieviruses in normal population in Delhi area, Indian J. Med. Res. 76:656–661.PubMedGoogle Scholar
  33. 33.
    Mukundan, P., and John, T. J., 1983, Prevalence and titres of neutralizing antibodies to group B coxsackieviruses, Indian J. Med. Res. 77:577–589.PubMedGoogle Scholar
  34. 34.
    Santhanam, S., and Choudhury, D. S., 1984, Antibodies against Coxsackie B2 virus in infants and children in Delhi,J. Commun. Dis. 16:304–306.PubMedGoogle Scholar
  35. 35.
    Morag, A., Margalith, M., Shuval, H. I., and Fattal, B., 1984, Acquisition of antibodies to various Coxsackie and echo viruses and hepatitis A virus in agricultural communal settlements in Israel, J. Med. Virol. 14:39–48.PubMedGoogle Scholar
  36. 36.
    Margalith, M., Fattal, B., Shuval, H. I., and Morag, A., 1986, Prevalence of antibodies to enteroviruses and varicella-zoster virus among residents and overseas volunteers at agricultural settlements in Israel,J. Med. Virol. 20:189–197.PubMedGoogle Scholar
  37. 37.
    Lau, R. S., 1983, Coxsackie B virus infections in New Zealand patients with cardiac and non-cardiac diseases,J. Med. Virol. 11:131–137.PubMedGoogle Scholar
  38. 38.
    Lerner, A. M., and Wilson, F. M., 1973, Virus myocardiopathy, Prog. Med. Virol. 15:63–91.PubMedGoogle Scholar
  39. 39.
    Hallam, N. F., Eglin, R. P., Holland, P., Bell, E. J., and Squier, M. V., 1986, Fatal Coxsackie B meningoencephalitis diagnosed by serology and in-situ nucleic acid hybridization, Lancet 2:1213–1214.PubMedGoogle Scholar
  40. 40.
    Cooper, J. B., Pratt, W. R., English, B. K., and Shearer, W. T., 1983, Coxsackievirus B3 producing fatal meningoencephalitis in a patient with X-linked agammaglobulinemia, Am. J. Dis. Child. 137:82–83.PubMedGoogle Scholar
  41. 41.
    Estes, M. L., and Rorke, L. B., 1986, Liquefactive necrosis in Coxsackie B encephalitis, Arch. Pathol. Lab. Med. 110:1090–1092.PubMedGoogle Scholar
  42. 42.
    Hirschman, S. Z., and Hammer, G. S., 1974, Coxsackie virus myopericarditis, Am. J. Cardiol. 34:224–232.PubMedGoogle Scholar
  43. 43.
    Woodruff, J. F., 1980, Viral myocarditis. A review, Am. J. Pathol. 101:427–529.Google Scholar
  44. 44.
    Reyes, M. P., and Lerner, A. M., 1985, Coxsackievirus myocarditis—with special reference to acute and chronic effects, Prog. Cardiovasc. Dis. 27:373–394.PubMedGoogle Scholar
  45. 45.
    Banatvala, J. E., 1983, Coxsackie B virus infections in cardiac disease, in: Recent Advances in Clinical Virology, Vol. 3 (A. P. Waterson, ed.), pp. 99–115, Churchill Livingstone, Edinburgh.Google Scholar
  46. 46.
    Sundar, S., Shyam, B., Gulathi, A. K., and Somani, P. N., Coxsackie—A viral carditis in eastern India, J.Assoc. Physicians India 32:501–503.Google Scholar
  47. 47.
    Morita, H., Kitaura, Y., Deguchi, H., Kotaka, M., Nakayama, Y., Suwa, M., Kino, M., Hirota, Y., and Kawamura, K., 1983, Pericarditis in a young adult—Clinical course and endomyocardial biopsy findings, Jpn. Circ. J. 47:1077–1083.PubMedGoogle Scholar
  48. 48.
    Read, R. B., Ede, R. J., Morgan-Capner, P., Moscoso, G., Portmann, B., and Williams, R., 1985, Myocarditis and fulminant hepatic failure from coxsackievirus B infection, Postgrad. Med. J. 61:749–752.PubMedGoogle Scholar
  49. 49.
    Frisk, G., Torfason, E. G., and Diderholm, H., 1984, Reverse radioimmunoassays of IgM and IgG antibodies to Coxsackie B viruses in patients with acute myopericarditis, J. Med. Virol. 14:191–200.PubMedGoogle Scholar
  50. 50.
    Tilzey, A. J., Signy, M., and Banatvala, J. E., 1986, Persistent Coxsackie B virus specific IgM response in patients with recurrent pericarditis. (Letter.) Lancet 1:1491–1492.PubMedGoogle Scholar
  51. 51.
    Bowles, N. E., Richardson, P. J., Olsen, E. G. J., and Archard, L. C., 1986, Detection of coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy, Lancet 1:1120–1122.PubMedGoogle Scholar
  52. 52.
    Rotbart, H. A., Levin, M. J., and Villarreal, L. P., 1984, Use of subgenomic poliovirus DNA hybridization probes to detect the major subgroups of enteroviruses, J. Clin. Microbiol 20:1105–1108.PubMedGoogle Scholar
  53. 53.
    Porres, E. R., Werthammer, J., Moss, N., Bernstein, J. M., and Belshe, R. B., 1985, Fatal coxsackievirus B4 infection in a neonate, South. Med. J. 78:1254–1256.PubMedGoogle Scholar
  54. 54.
    Barson, W. J., and Reiner, C. B., 1986, Coxsackievirus B2 infection in a neonate with incontinentia pigmenti, Pediatrics 77:897–900.PubMedGoogle Scholar
  55. 55.
    Rozkovec, A., Cambridge, G., King, M., and Hallidie-Smith, K. A., 1985, Natural history of left ventricular function in neonatal Coxsackie myocarditis, Pediatr. Cardiol. 6:151–156.PubMedGoogle Scholar
  56. 56.
    Schurmann, W., Statz, A., Mertens, T., Gladtke, E., and Eggers, H. J., 1983, Two cases of Coxsackie B2 infection in neonates: Clinical, virological, and epidemiological aspects, Eur. J. Pediatr. 140:59–63.PubMedGoogle Scholar
  57. 57.
    Iwasaki, T., Monma, N., Satodate, R., Kawana, R., and Kurata, T., 1985, An immunofluorescent study of generalized Coxsackie virus B3 infection in a newborn infant, Acta Pathol. Jpn. 35:741–748.PubMedGoogle Scholar
  58. 58.
    Fisher-Hoch, S. P., Gould, J., and Latham, P., 1982, Coxsackie B virus infection associated with hypoparathyroidism in a neonate, Lancet 2:1395–1396.PubMedGoogle Scholar
  59. 59.
    Kaplan, M. H., Klein, S. W., McPhee, J., and Harper, R. G., 1983, Group B coxsackievirus infections in infants younger than three months of age: A serious childhood illness, Rev. Infect. Dis. 5:1019–1032.PubMedGoogle Scholar
  60. 60.
    Modlin, J. F., 1986, Perinatal echovirus infection: Insights from a literature review of 61 cases of serious infection and 16 outbreaks in nurseries, Rev. Infect. Dis. 8:918–926.PubMedGoogle Scholar
  61. 61.
    Reyes, M. P., Zalenski, D., Smith, F., Wilson, F. M., and Lerner, A. M., 1986, Cox-sackievirus-positive cervices in women with febrile illnesses during the third trimester in pregnancy, Am. J. Obstet. Gynecol. 155:159–161.PubMedGoogle Scholar
  62. 62.
    Barrett-Conner, E., 1985, Is insulin-dependent diabetes mellitus caused by coxsackievirus B infection? A review of the epidemiologic evidence, Rev. Infect. Dis. 7:207–215.Google Scholar
  63. 63.
    Nihalani, K. D., Pethani, R. R., Menon, P. S., and Mehtalia, S. D., 1982, Coxsackie B4 virus causing insulin dependent diabetes mellitus, myopericarditis and encephalitis— A case report, J.Assoc. Physicians India 30:107–109.Google Scholar
  64. 64.
    Niklasson, B. S., Dobersen, M. J., Peters, C. J., Ennis, W. H., and Möller, E., 1985, An outbreak of coxsackievirus B infection followed by one case of diabetes mellitus, Scand.J. Infect. Dis. 17:15–18.PubMedGoogle Scholar
  65. 65.
    Mirkovic, R. R., Varma, S. K., and Yoon, J. W., 1984, Incidence of coxsackievirus B type 4 (CB4) infections concomitant with onset of insulin-dependent diabetes mellitus,J. Med. Virol. 14:9–16.PubMedGoogle Scholar
  66. 66.
    Asplin, C. M., Cooney, M. K., Crossley, J. R., Dornan, T. L., Raghu, P., and Palmer, J. P., 1982, Coxsackie B4 infection and islet cell antibodies three years before overt diabetes,J. Pediatr. 101:398–400.PubMedGoogle Scholar
  67. 67.
    Champsaur, H., 1980, Diabetes and Coxsackie virus B5 infection, Lancet 1:251.PubMedGoogle Scholar
  68. 68.
    Mertens, T., Gruneklee, D., and Eggers, H. J., 1983, Neutralizing antibodies against Coxsackie B viruses in patients with recent onset of type I diabetes, Eur. J. Pediatr. 140:293–294.PubMedGoogle Scholar
  69. 69.
    Friman, G., Fohlman, J., Frisk, G., Diderholm, H., Ewald, U., Kobbah, M., and Tuvemo, T., 1985, An incidence peak of juvenile diabetes. Relation to Coxsackie B virus immune response, Acta Paediatr Scand. [Suppl] 320:14–19.Google Scholar
  70. 70.
    Frisk, G., Fohlman, J., Kobbah, M., Ewald, U., Tuvemo, T., Diderholm, H., and Friman, G., 1985, High frequency of coxsackie-B-virus-specific IgM in children developing type 1 diabetes during a period of high diabetes morbidity, J. Med. Virol. 17:219–227.PubMedGoogle Scholar
  71. 71.
    Alberti, A. M., Amato, C., Candela, A., Costantino, F., Grandolfo, M. E., Lombardi, F., Novello, F., Orsini, M., and Santoro, R., 1985, Serum antibodies against Coxsackie Bl-6 viruses in type 1 diabetics, Acta Diabetol. Lat. 22:33–38.PubMedGoogle Scholar
  72. 72.
    Palmer, J. P., Cooney, M. K., Ward, R. H., Hansen, J. A., Brodsky, J. B., Ray, C. G., Crossley, J. R., Asplin, C. M., and Williams, R. H., 1982, Reduced Coxsackie antibody titers in type 1 (insulin-dependent) diabetic patients presenting during an outbreak of Coxsackie B3 and B4 infection, Diabetologia 22:426–429.PubMedGoogle Scholar
  73. 73.
    King, M. L., Shaikh, A., Bidwell, D., Voller, A., and Banatvala, J. E., 1983, Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus, Lancet 1:1397–1399.PubMedGoogle Scholar
  74. 74.
    Banatvala, J. E., Bryant, J., Schernthaner, G., Borkenstein, M., Schober, E., Brown, D., De Silva, L. M., Menser, M. A., and Silink, M., 1985, Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia, Lancet 1:1409–1412.PubMedGoogle Scholar
  75. 75.
    Schernthaner, G., Banatvala, J. E., Scherbaum, W., Bryant, J., Borkenstein, M., Schober, E., and Mayr, W. R., 1985, Coxsackie-B-virus-specific IgM responses, complement-fixing islet-cell antibodies, HLA DR antigens, and C-peptide secretion in insulin-dependent diabetes mellitus, Lancet 2:630–632.PubMedGoogle Scholar
  76. 76.
    Eberhardt, M. S., Wagener, D. K., Orchard, T. J., LaPorte, R. E., Cavender, D. E., Rabin, B. S., Atchison, R. W., Kuller, L. H., Drash, A. L., and Becker, D. J., 1985, HLA heterogeneity of insulin-dependent diabetes mellitus at diagnosis. The Pittsburgh IDDM study, Diabetes 34:1247–1252.PubMedGoogle Scholar
  77. 77.
    O’Neill, D., McArthur, J. D., Kennedy, J. A., and Clements, G., 1983, Coxsackie B virus infection in coronary care unit patients,J. Clin. Pathol. 36:658–661.PubMedGoogle Scholar
  78. 78.
    Bell, E. J., Irvine, K. G., Gardiner, A. J., and Rodger, J. C., 1983, Coxsackie B infection in a general medical unit, Scott. Med. J. 28:157–159.PubMedGoogle Scholar
  79. 79.
    Nikoskelainen, J., Kalliomaki, J. L., Lapinleimu, K., Stenvik, M., and Halonen, P. E., 1983, Coxsackie B virus antibodies in myocardial infarction, Acta Med. Scand. 214:29–32.PubMedGoogle Scholar
  80. 80.
    Lau, R. C., 1982, Coxsackie B virus infection in acute myocardial infarction and adult heart disease, Med. J. Aust. 2:520–522.PubMedGoogle Scholar
  81. 81.
    Lau, R. C., 1986, Coxsackie B virus-specific IgM responses in coronary care unit patients,/ Med. Virol. 18:193–198.Google Scholar
  82. 82.
    Hannington, G., Booth, J. C., Bowes, R. J., and Stern, H., 1986, Coxsackie B virus-specific IgM antibody and myocardial infarction,J. Med. Microbiol. 21:287–291.PubMedGoogle Scholar
  83. 83.
    Hurst, N. P., Martynoga, A. G., Nuki, G., Sewell, J. R., Mitchell, A., and Hughes, G. R., 1983, Coxsackie B infection and arthritis, Br. Med. J. 286:605.Google Scholar
  84. 84.
    Heaton, D. C., and Moller, P. W., 1985, Still’s disease associated with Coxsackie infection and haemophagocytic syndrome, Ann. Rheum. Dis. 44:341–344.PubMedGoogle Scholar
  85. 85.
    Christensen, M. L., Pachman, L. M., Schneiderman, R., Patel, D. C., and Friedman, J. M., 1986, Prevalence of Coxsackie B virus antibodies in patients with juvenile der-matomyositis, Arthńtis Rheum. 29:1365–1370.Google Scholar
  86. 86.
    Gauntt, C. J., Gudvangen, R. J., Brans, Y. W., and Marlin, A. E., 1985, Coxsackievirus group B antibodies in the ventricular fluid of infants with severe anatomic defects in the central nervous system, Pediatrics 76:64–68.PubMedGoogle Scholar
  87. 87.
    Melnick, J. L., Wenner, H. A., and Phillips, C. A., 1979, Enteroviruses, in: Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections (E. H. Lennette and N. J. Schmidt, eds.), pp. 471–534, American Public Health Association, Washington, D.C.Google Scholar
  88. 88.
    Patel, J. R., Daniel, J., Mathan, M., and Mathan, V. I., 1984, Isolation and identification of enteroviruses from faecal samples in a differentiated epithelial cell line (HRT-18) derived from human rectal carcinoma, J. Med. Virol. 14:255–261.Google Scholar
  89. 89.
    Patel, J. R., Daniel, J., and Mathan, V. I., 1985, A comparison of the susceptibility of three human gut tumour-derived differentiated epithelial cell lines, primary monkey kidney cells and human rhabdomyosarcoma cell line to 66-prototype strains of human enteroviruses, J.Virol. Methods 12:209–216.Google Scholar
  90. 90.
    Dagan, R., and Menegus, M. A., 1986, A combination of four cell types for rapid detection of enteroviruses in clinical specimens,J. Med. Virol. 19:219–228.PubMedGoogle Scholar
  91. 91.
    Tracy, S., 1985, Comparison of genomic homologies in the coxsackievirus B group by use of cDNA: RNA dot-blot hybridization,J. Clin. Microbiol. 21:371–374.PubMedGoogle Scholar
  92. 92.
    Tracy, S., 1984, A comparison of genomic homologies among the coxsackievirus B group: Use of fragments of the cloned coxsackievirus B3 genome as probes,J. Gen. Virol. 65:2167–2172.PubMedGoogle Scholar
  93. 93.
    Hypiä, T., Stålhandske, P., Vainionpää, R., and Pettersson, U., 1984, Detection of enteroviruses by spot hybridization, J. Clin. Microbiol. 19:436–438.Google Scholar
  94. 94.
    Rotbart, H. A., Levin, M. J., Villarreal, L. P., Tracy, S. M., Semler, B. L., and Wimmer, E., 1985, Factors affecting the detection of enteroviruses in cerebrospinal fluid with coxsackievirus B3 and poliovirus 1 cDNA probes, J. Clin. Microbiol. 22:220–224.PubMedGoogle Scholar
  95. 95.
    Dörries, R., and Ter Meulen, V., 1983, Specificity of IgM antibodies in acute human coxsackievirus B infections, analysed by indirect solid phase enzyme immunoassay and immunoblot technique, J.Gen. Virol. 64:159–167.Google Scholar
  96. 96.
    Morgan-Capner, P., and McSorley, C., 1983, Antibody capture radioimmunoassay (MACRIA) for coxsackievirus B4 and B5-specific IgM,J. Hyg. (Lond.) 90:333–349.Google Scholar
  97. 97.
    Hannington, G., Booth, J. C., Wiblin, C. N., and Stern, H., 1983, Indirect enzyme-linked immunosorbent assay (ELISA) for detection of IgG antibodies against Coxsackie B viruses, J. Med. Microbiol. 16:459–465.Google Scholar
  98. 98.
    Chan, D., and Hammond, G. W., 1985, Comparison of serodiagnosis of group B Coxsackie virus infections by an immunoglobulin M capture enzvme immunoassay versus microneutralization,J. Clin. Microbiol. 21:830–834.PubMedGoogle Scholar
  99. 99.
    McCartney, R. A., Banatvala, J. E., and Bell, E. J., 1986, Routine use of µ-antibody-capture ELISA for the serological diagnosis of Coxsackie B virus infections,J. Med. Virol. 19:205–212.PubMedGoogle Scholar
  100. 100.
    Loh, P. C., Dow, M. A., and Fujioka, R. S., 1985, Use of the nitrocellulose-enzyme immunosorbent assay for rapid, sensitive and quantitative detection of human enteroviruses, J.Virol. Methods 12:225–234.Google Scholar
  101. 101.
    Tracy, S., and Latham, A., 1986, Rapid identification of Coxsackie B viruses after immunoprecipitation and nucleic acid hybridization, Diagn. Microbiol. Infect. Dis. 4:327–333.PubMedGoogle Scholar
  102. 102.
    Pattison, J. R., 1983, Tests for Coxsackie B virus-specific IgM,J. Hyg. (Lond.) 90:327–332.Google Scholar
  103. 103.
    Kew, O. M., and Nottay, B. K., 1984, Evolution of the oral poliovaccine strains in humans occurs by both mutation and intramolecular recombination, in: Modern Approaches to Vaccines (R. M. Chanock and R. A. Lerner, eds.), pp. 357–367, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.Google Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • Mark A. Pallansch
    • 1
  1. 1.Division of Viral Diseases, Center for Infectious Diseases, Centers for Disease Control, U.S. Public Health ServiceU.S. Department of Health and Human ServicesAtlantaUSA

Personalised recommendations